{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:27:56Z","timestamp":1782390476278,"version":"3.54.5"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>\n                    Endometrial hyperplasia (EH) is a precursor lesion to endometrial carcinoma (EC). Risks for EC include genetic, hormonal and metabolic factors most notably those associated with obesity: rates are rising and there is concern that cases in pre-menopausal women may remain undetected. Making an accurate distinction between benign and pre-malignant disease is both a challenge for the pathologist and important to the gynecologist who wants to deliver the most appropriate care to meet the needs of the patient. Premalignant change may be recognized by histological changes of endometrial hyperplasia (which may occur with or without atypia) and endometrial intraepithelial neoplasia (EIN). In this study we created a tissue resource of EH samples diagnosed between 2004 and 2009 (\n                    <jats:italic>n<\/jats:italic>\n                    = 125) and used this to address key questions: 1. Are the EIN\/WHO2014 diagnostic criteria able to consistently identify premalignant endometrium? 2. Can computer aided image analysis inform identification of EIN? 3. Can we improve diagnosis by incorporating analysis of protein expression using immunohistochemistry. Our findings confirmed the inclusion of EIN in diagnostic criteria resulted in a better agreement between expert pathologists compared with the previous WHO94 criteria used for the original diagnosis of our sample set. A computer model based on assessment of stromal:epithelial ratio appeared most accurate in classification of areas of tissue without EIN. From an extensive panel of putative endometrial protein tissue biomarkers a score based on assessment of HAND2, PTEN, and PAX2 was able to identify four clusters one of which appeared to be more likely to be benign. In summary, our study has highlighted new opportunities to improve diagnosis of pre-malignant disease in endometrium and provide a platform for further research on this important topic.\n                  <\/jats:p>","DOI":"10.3389\/frph.2022.896170","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T02:23:15Z","timestamp":1652322195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers"],"prefix":"10.3389","volume":"4","author":[{"given":"Peter A.","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Esnal-Zufiaurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Simon","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair R. W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa T. K.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/humupd\/dmw042","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Hum Reprod Update."},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature."},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/00016348609158227","article-title":"Histopathological findings in 226 women with post-menopausal uterine bleeding","volume":"65","author":"Lidor","year":"1986","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1471-0528.14385","article-title":"Premenopausal abnormal uterine bleeding and risk of endometrial cancer","volume":"124","author":"Pennant","year":"2017","journal-title":"BJOG."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod."},{"key":"B6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD012214","DOI":"10.1002\/14651858.CD012214.pub2","article-title":"Metformin for endometrial hyperplasia","volume":"10","author":"Clement","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/ijgc-2021-002699","article-title":"Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis","volume":"31","author":"Chae-Kim","year":"2021","journal-title":"Int J Gynecol Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.soard.2014.12.010","article-title":"Endometrial histology in severely obese bariatric surgery candidates: an exploratory analysis","volume":"11","author":"Kaiyrlykyzy","year":"2015","journal-title":"Surg Obes Relat Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ijc.31913","article-title":"The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk","volume":"144","author":"Mackintosh","year":"2019","journal-title":"Int J Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1158\/1940-6207.CAPR-21-0229","article-title":"Weight loss during intrauterine progestin treatment for obesity-associated atypical hyperplasia and early-stage cancer of the endometrium","volume":"14","author":"Barr","year":"2021","journal-title":"Cancer Prev Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ygyno.2013.12.005","article-title":"Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery","volume":"133","author":"Argenta","year":"2014","journal-title":"Gynecol Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.2004.021071","article-title":"EIN and WHO94","volume":"58","author":"Baak","year":"2005","journal-title":"J Clin Pathol."},{"key":"B15","first-page":"4483","article-title":"Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer","volume":"56","author":"Mutter","year":"1996","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/jcp.55.5.326","article-title":"Diagnosis of premalignant endometrial disease","volume":"55","author":"Mutter","year":"2002","journal-title":"J Clin Pathol."},{"key":"B17","article-title":"WHO Classification of Tumours of Female Reproductive Organs","year":"2014"},{"key":"B18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.humpath.2005.02.018","article-title":"Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression","volume":"36","author":"Baak","year":"2005","journal-title":"Hum Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/modpathol.2008.197","article-title":"Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma","volume":"22","author":"Jarboe","year":"2009","journal-title":"Mod Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65492-2","article-title":"hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis","volume":"155","author":"Esteller","year":"1999","journal-title":"Am J Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamaoncol.2018.0280","article-title":"Findings linking mismatch repair mutation with age at endometrial and ovarian cancer onset in lynch syndrome-reply","volume":"4","author":"Crosbie","year":"2018","journal-title":"JAMA Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1126\/science.1197454","article-title":"The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2","volume":"331","author":"Li","year":"2011","journal-title":"Science."},{"key":"B24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/jclinpath-2017-204387","article-title":"Immunohistochemistry on old archival paraffin blocks: is there an expiry date?","volume":"70","author":"Grillo","year":"2017","journal-title":"J Clin Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"Kobel","year":"2016","journal-title":"J Pathol Clin Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1309\/AJCP8OMLT7KDWLMF","article-title":"Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia","volume":"138","author":"Quick","year":"2012","journal-title":"Am J Clin Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/PGP.0000000000000099","article-title":"The immunohistochemistry signature of mismatch repair (MMR) proteins in a multiethnic Asian cohort with endometrial carcinoma","volume":"33","author":"Woo","year":"2014","journal-title":"Int J Gynecol Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/cjp2.22","article-title":"Increased proliferation in atypical hyperplasia\/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors","volume":"1","author":"Ayhan","year":"2015","journal-title":"J Pathol Clin Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0002-9440(10)64434-3","article-title":"Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays","volume":"161","author":"Liu","year":"2002","journal-title":"Am J Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/gyno.1999.5580","article-title":"Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos?","volume":"76","author":"Mutter","year":"2000","journal-title":"The endometrial collaborative group. Gynecol Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10552-013-0333-7","article-title":"Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones","volume":"25","author":"Stevens","year":"2014","journal-title":"Cancer Causes Control."},{"key":"B34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2016.08.333","article-title":"Working together to shape the endometrial cancer research agenda: the top ten unanswered research questions","volume":"143","author":"Wan","year":"2016","journal-title":"Gynecol Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00404-019-05103-1","article-title":"Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better?","volume":"299","author":"Raffone","year":"2019","journal-title":"A systematic review and meta-analysis. Arch Gynecol Obstet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/his.13776","article-title":"Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria","volume":"74","author":"Travaglino","year":"2019","journal-title":"Histopathology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/cncr.21058","article-title":"The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the (1994)","volume":"103","author":"Baak","year":"2005","journal-title":"World Health Organization classification system. Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1002\/cncr.23808","article-title":"Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies","volume":"113","author":"Lacey JV","year":"2008","journal-title":"Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.3390\/jcm9113697","article-title":"Digital pathology: advantages, limitations and emerging perspectives","volume":"9","author":"Jahn","year":"2020","journal-title":"J Clin Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.1158\/0008-5472.CAN-08-1154","article-title":"PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma","volume":"68","author":"Lacey JV","year":"2008","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cjp2.243","article-title":"Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features","volume":"8","author":"Kang","year":"2022","journal-title":"J Pathol Clin Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1001551","DOI":"10.1371\/journal.pmed.1001551","article-title":"Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development","volume":"10","author":"Jones","year":"2013","journal-title":"PLoS Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/PGP.0000000000000106","article-title":"Heart and neural crest derivatives expressed transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and type I endometrial carcinoma","volume":"34","author":"Buell-Gutbrod","year":"2015","journal-title":"Int J Gynecol Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ygyno.2021.10.079","article-title":"The cost of diagnosing endometrial cancer: quantifying the healthcare cost of an abnormal uterine bleeding workup","volume":"164","author":"Warring","year":"2022","journal-title":"Gynecol Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.21037\/apm-21-2516","article-title":"Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis","volume":"10","author":"Su","year":"2021","journal-title":"Ann Palliat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1111\/cas.14571","article-title":"Cancer-associated mutations in normal human endometrium: surprise or expected?","volume":"111","author":"Kyo","year":"2020","journal-title":"Cancer Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2559.2009.03392.x","article-title":"DNA mismatch repair deficiency in sporadic colorectal cancer and lynch syndrome","volume":"56","author":"Poulogiannis","year":"2010","journal-title":"Histopathology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","article-title":"The proportion of endometrial cancers associated with lynch syndrome: a systematic review of the literature and meta-analysis","volume":"21","author":"Ryan","year":"2019","journal-title":"Genet Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1003263","DOI":"10.1371\/journal.pmed.1003263","article-title":"The proportion of endometrial tumours associated with lynch syndrome (PETALS): A prospective cross-sectional study","volume":"17","author":"Ryan","year":"2020","journal-title":"PLoS Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/cancers11101572","article-title":"Proteomic biomarkers for the detection of endometrial cancer","volume":"11","author":"Njoku","year":"2019","journal-title":"Cancers"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/cancers13194764","article-title":"HE4 as a Biomarker for Endometrial Cancer","volume":"13","author":"Behrouzi","year":"2021","journal-title":"Cancers"},{"key":"B52","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cancers12020276","article-title":"Baseline Serum HE4 but not tissue he4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer","volume":"12","author":"Behrouzi","year":"2020","journal-title":"Cancers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ygyno.2017.07.130","article-title":"Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer","volume":"147","author":"Knific","year":"2017","journal-title":"Gynecol Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ygyno.2020.11.004","article-title":"HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: a retrospective study in a cohort with histological proof of lymph node status","volume":"160","author":"O'toole","year":"2021","journal-title":"Gynecol Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"21694","DOI":"10.1038\/s41598-021-01263-w","article-title":"Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma","volume":"11","author":"Quan","year":"2021","journal-title":"Sci Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41366-021-01027-6","article-title":"The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium","volume":"46","author":"Naqvi","year":"2021","journal-title":"Int J Obes"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2022.896170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T02:23:21Z","timestamp":1652322201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2022.896170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":56,"alternative-id":["10.3389\/frph.2022.896170"],"URL":"https:\/\/doi.org\/10.3389\/frph.2022.896170","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.27.22271450","asserted-by":"object"}]},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"article-number":"896170"}}